Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Adolfsson

Showing results (51-60 of 168) with videos related to

Pageof 17
Sort By:
European Urology|November 7, 2016
Quantifying the Transition from Active Surveillance to Watchful Waiting Among Men with Very Low-risk Prostate CancerMieke Van Hemelrijck, Hans Garmo, Lars Lindhagen, et al.
Scandinavian Journal of Urology|October 27, 2018
Work-up and treatment of prostate cancer before and after publication of the first national guidelines on prostate cancer care in SwedenHampus Nugin, Yasin Folkvaljon, Jan-Erik Damber, et al.
Plos One|April 13, 2018
A case-control study of lower urinary-tract infections, associated antibiotics and the risk of developing prostate cancer using PCBaSe 3.0Beth Russell, Hans Garmo, Kerri Beckmann, et al.
Cancer|June 8, 2012
Primary cancers before and after prostate cancer diagnosisMieke Van Hemelrijck, Linda Drevin, Lars Holmberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2015
Risk and timing of cardiovascular disease after androgen-deprivation therapy in men with prostate cancerSean O'Farrell, Hans Garmo, Lars Holmberg, et al.
European Journal of Cancer (Oxford, England : 1990)|April 17, 2014
Patterns of androgen deprivation therapies among men diagnosed with localised prostate cancer: a population-based studyMagdalena Lycken, Hans Garmo, Jan Adolfsson, et al.
European Urology Open Science|August 2, 2021
The STHLM3-model, Risk-based Prostate Cancer Testing Identifies Men at High Risk Without Inducing Negative Psychosocial EffectsMarie Koitsalu, Martin Eklund, Jan Adolfsson, et al.
European Urology|December 9, 2014
Quantifying observational evidence for risk of fatal and nonfatal cardiovascular disease following androgen deprivation therapy for prostate cancer: a meta-analysisCecilia Bosco, Zsolt Bosnyak, Anders Malmberg, et al.
Acta Paediatrica (Oslo, Norway : 1992)|April 17, 2023
A systematic review of hormone treatment for children with gender dysphoria and recommendations for researchJonas F Ludvigsson, Jan Adolfsson, Malin Höistad, et al.
BJU International|March 16, 2006
A single-nucleotide polymorphism in the XPG gene, and tumour stage, grade, and clinical course in patients with nonmuscle-invasive neoplasms of the urinary bladderShigeru Sakano, Rajiv Kumar, Per Larsson, et al.
Pageof 17

Showing results (51-60 of 168) with videos related to

Sort By:
Pageof 17
European Urology|November 7, 2016
Quantifying the Transition from Active Surveillance to Watchful Waiting Among Men with Very Low-risk Prostate CancerMieke Van Hemelrijck, Hans Garmo, Lars Lindhagen, et al.
Scandinavian Journal of Urology|October 27, 2018
Work-up and treatment of prostate cancer before and after publication of the first national guidelines on prostate cancer care in SwedenHampus Nugin, Yasin Folkvaljon, Jan-Erik Damber, et al.
Plos One|April 13, 2018
A case-control study of lower urinary-tract infections, associated antibiotics and the risk of developing prostate cancer using PCBaSe 3.0Beth Russell, Hans Garmo, Kerri Beckmann, et al.
Cancer|June 8, 2012
Primary cancers before and after prostate cancer diagnosisMieke Van Hemelrijck, Linda Drevin, Lars Holmberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2015
Risk and timing of cardiovascular disease after androgen-deprivation therapy in men with prostate cancerSean O'Farrell, Hans Garmo, Lars Holmberg, et al.
European Journal of Cancer (Oxford, England : 1990)|April 17, 2014
Patterns of androgen deprivation therapies among men diagnosed with localised prostate cancer: a population-based studyMagdalena Lycken, Hans Garmo, Jan Adolfsson, et al.
European Urology Open Science|August 2, 2021
The STHLM3-model, Risk-based Prostate Cancer Testing Identifies Men at High Risk Without Inducing Negative Psychosocial EffectsMarie Koitsalu, Martin Eklund, Jan Adolfsson, et al.
European Urology|December 9, 2014
Quantifying observational evidence for risk of fatal and nonfatal cardiovascular disease following androgen deprivation therapy for prostate cancer: a meta-analysisCecilia Bosco, Zsolt Bosnyak, Anders Malmberg, et al.
Acta Paediatrica (Oslo, Norway : 1992)|April 17, 2023
A systematic review of hormone treatment for children with gender dysphoria and recommendations for researchJonas F Ludvigsson, Jan Adolfsson, Malin Höistad, et al.
BJU International|March 16, 2006
A single-nucleotide polymorphism in the XPG gene, and tumour stage, grade, and clinical course in patients with nonmuscle-invasive neoplasms of the urinary bladderShigeru Sakano, Rajiv Kumar, Per Larsson, et al.
Pageof 17